Benalgis Uses, Dosage, Side Effects and more
Benalgis has been investigated for the treatment and prevention of Diabetic Nephropathy and Diabetes Mellitus, Type 2.
| Attribute | Details |
|---|---|
| Trade Name | Benalgis |
| Generic | Benfotiamine |
| Benfotiamine Other Names | Benfotiamina, Benfotiamine, Benphothiamine, Benzoylthiamine monophosphate, S-benzoylthiamine monophosphate |
| Weight | 100mg, 40mg, 75mg |
| Type | Tablet |
| Formula | C19H23N4O6PS |
| Weight | Average: 466.45 Monoisotopic: 466.107592649 |
| Groups | Approved, Experimental |
| Therapeutic Class | |
| Manufacturer | Franco Indian Pharmaceuticals Pvt Ltd |
| Available Country | India |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Benalgis is a derivative of thiamine thought to be useful in the management of diabetic neuropathy, although evidence is lacking.
Benalgis is also used to associated treatment for these conditions: Thiamine Deficiency
